See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2019_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,385,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,678,700,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,471,500,000 |
| 3 | remainder_Assets | 396,700,000 |
| 4 | LiabilitiesCurrent | 1,174,000,000 |
| 5 | LiabilitiesNoncurrent | 2,657,300,000 |
| 6 | remainder_Liabilities | 935,300,000 |
| 7 | CostOfGoodsAndServicesSold | 245,634,375 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,130,638,414 |
| 9 | ResearchAndDevelopmentExpense | 7,069,468,368 |
| 10 | remainder_Expenses | 579,764,641 |
| 11 | remainder_Revenues | 5,592,292,563 |
| 12 | remainder_NetIncome | 53,114,692 |
| 13 | remainder_ComprehensiveNetIncome | -44,813,694 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,931,900,000 |
| 1 | Liabilities | 4,766,600,000 |
| 2 | Expenses | 9,025,505,798 |
| 3 | Revenues | 5,592,292,563 |
| 4 | StockholdersEquity | 9,165,300,000 |
| 5 | NetIncome | -3,380,098,543 |
| 6 | ComprehensiveNetIncome | -3,402,505,390 |
| 7 | BaseVar | 16,707,113,374 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.77 |
| 9 | EconomicCapitalRatio | 2.87 |
Edgar->Model Mapping
Feature Distribution
Change over Time
